UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Lyell Wealth Management LP

Lyell Wealth Management LP decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 59.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,377 shares of the healthcare conglomerate's stock after selling 4,904 shares during the period. Lyell Wealth Management LP's holdings in UnitedHealth Group were worth $1,708,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. M&T Bank Corp boosted its position in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock valued at $128,975,000 after purchasing an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC raised its stake in shares of UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock worth $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. boosted its holdings in shares of UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock valued at $26,060,000 after acquiring an additional 41,308 shares in the last quarter. Parsifal Capital Management LP purchased a new position in UnitedHealth Group during the third quarter worth about $21,165,000. Finally, Signal Advisors Wealth LLC boosted its holdings in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after purchasing an additional 1,051 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by insiders.

UnitedHealth Group Trading Down 7.3 %

Shares of NYSE UNH traded down $36.84 on Friday, reaching $465.58. 19,847,353 shares of the company traded hands, compared to its average volume of 4,805,500. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a 50 day moving average of $519.27 and a 200 day moving average of $560.54. The stock has a market capitalization of $428.46 billion, a PE ratio of 30.04, a P/E/G ratio of 1.40 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same period in the previous year, the company earned $5.83 EPS. The business's quarterly revenue was up 6.8% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently commented on the company. Wells Fargo & Company reduced their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Finally, Oppenheimer raised their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.